Vitamin D for Chronic Pain After Burns
Trial Summary
What is the purpose of this trial?
The goal of this pilot clinical trial is to learn whether vitamin D is able to prevent chronic pain following burn injury and to determine what biological mechanisms are engaged by Vitamin D following burn injury. The main question\[s\] it aims to answer are: * Is the clinical trial protocol feasible? * Is Vitamin D administration following burn injury safe? * How does vitamin D cause changes in the immune system in the aftermath of burn injury? Following informed consent, participants will be asked to: * Take 6 capsules by mouth one time following burn injury (Vitamin D or Placebo) * Provide a blood sample at baseline and 6 weeks following injury * Fill out surveys daily while in the hospital, weekly through 6 weeks, and at 3 months and 6 months. Researchers will compare Vitamin D and placebo groups to see if there are differences in adverse effects (side effects), chronic pain, and profiles of immune cells from collected blood samples.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you are taking Vitamin D supplements in excess of 800 IU daily, you may not be eligible to participate.
What evidence supports the effectiveness of the drug Vitamin D2 (Ergocalciferol) for chronic pain after burns?
Research suggests that low levels of Vitamin D are linked to worse chronic pain outcomes, and supplementation may improve pain, sleep, and quality of life in chronic pain patients. Vitamin D is thought to help with pain by interacting with pain signaling pathways and immune cells, although more studies are needed to understand these effects fully.12345
Is Vitamin D safe for use in humans, particularly for those with chronic pain after burns?
Vitamin D, including forms like ergocalciferol (Vitamin D2), is generally considered safe for humans. It is important for bone and muscle health, and deficiencies can lead to issues like muscle weakness and itching, which are common in burn patients. However, more research is needed to fully understand its safety and effects in adult burn patients.26789
How does the drug Ergocalciferol differ from other treatments for chronic pain after burns?
Ergocalciferol (Vitamin D2) is unique because it addresses chronic pain potentially linked to vitamin D deficiency, which is not typically targeted by standard pain medications. Unlike traditional analgesics, it may help improve pain by correcting vitamin D levels, especially in individuals with compromised vitamin D status, which is common in burn patients.1281011
Research Team
Matthew C Mauck, MD PhD
Principal Investigator
University of North Carolina, Chapel Hill
Eligibility Criteria
Adults aged 18-70 with thermal burns covering less than 30% of their body, experiencing significant pain (β₯7/10), and admitted for surgical burn wound management. Participants must be alert, speak English, willing to take study medication, have a smartphone, and not have severe kidney disease or certain other health conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants take 6 capsules by mouth one time following burn injury (Vitamin D or Placebo)
Monitoring
Participants provide a blood sample at baseline and 6 weeks following injury and fill out surveys daily while in the hospital, weekly through 6 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, with surveys at 3 months and 6 months
Treatment Details
Interventions
- Ergocalciferol
- Placebo
Ergocalciferol is already approved in United States, European Union, Canada for the following indications:
- Rickets
- Osteomalacia
- Hypoparathyroidism
- Vitamin D deficiency
- Rickets
- Osteomalacia
- Hypoparathyroidism
- Vitamin D deficiency
- Rickets
- Osteomalacia
- Hypoparathyroidism
- Vitamin D deficiency
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborator